ReviewActa pharmacologica Sinica2025

How improvements in US FDA regulatory process and procedures led to the drug approval for first ever treatment of a common liver disease.

Brian E HarveyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.